UPDATE: Imperial Capital Initiates Coverage on LifeVantage Corporation with In-Line Rating, $2.10 PT Awaiting Renewed Distributor Growth

In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on LifeVantage Corporation LFVN with an In-Line rating and $2.10 price target. In the report, Imperial Capital noted, “We are initiating coverage of LifeVantage Corporation (LFVN) with an In-Line rating and one-year price target of $2.10. Our price target is about 40% above the recent share price. LFVN's business has experienced rapid revenue growth since FY09 as the company transitioned from retail store distribution to a network marketing (multi-level marketing) model for its anti-aging nutraceutical product, Protandim. Our In-Line rating reflects some near-term caution for two reasons: 1) revenue growth has declined in the last two quarters, in part, due to a slowdown in active distributor growth and a weakening Japanese yen, 2) near-term visibility is clouded as the company has lost near-term distributor momentum which we believe is critical in a multi-level marketing model. LFVN's recent additions to management and initiatives to revive distributor and active customer growth look positive; however, we prefer to have more visibility before committing to these shares, which currently trade consistent with its multi-level marketing peers.” LifeVantage Corporation closed on Tuesday at $1.47.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorInitiationAnalyst Ratingsimperial capitalMitchell B. Pinheiro
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!